ACL vs AGN

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

44LOW

AGN

ARGENICA FPO [AGN]

44LOW

Score Breakdown

ACL AGN
Technical
65
38
Catalyst
50
53
Sentiment
50
50
Fundamental
73
44
Momentum
37
19
Risk Gate
36
42

Key Metrics

ACL Metric AGN
$372.1MMarket Cap$20.6M
626KAvg Volume (20d)179K
+6.1%Short InterestN/A
$3.24052-Week High$0.855
$1.91552-Week Low$0.160
+2.8%Daily Change+0.0%
$2.010Entry Price$0.160
+16.7%ROE-117.8%
+3.6%Profit MarginN/A

Active Signals

ACL Signals

●RSI drifting toward oversold territory — worth watching
●MACD just crossed bullish — momentum is shifting to the upside
●Above-average volume (1.8x) on a green day — buyers stepping up
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.5x)
●EPS estimates revised upward (+10pts)
●Post-earnings drift: negative surprise (SUE -10)

AGN Signals

●RSI is looking oversold — historically a spot where stocks tend to bounce
●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
●Trading below both moving averages — the trend is working against this one
●Volume surging at 2.4x normal while price falls — heavy selling pressure
●Took a hit — down 17.9% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it

Ask Scout AI to compare ACL and AGN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ACL Full Analysis → AGN Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).